DBV Technologies has announced a placement of ADS for approximately $30 million as part of its At-The-Market (ATM) program on the Nasdaq. The company will issue and place new ordinary shares with Artisan Partners Limited Partnership in the form of American Depositary Shares (ADS). This offering is part of a financing program to extend the company’s cash runway until the end of the fourth quarter of 2026. The new shares represent a dilution of about 5.96% and will be traded on the Nasdaq Capital Market and Euronext Paris. The company’s focus is on developing treatment options for food allergies using its VIASKIN® patch technology.

Read more at GlobeNewswire: DBV Technologies annonce un placement d’ADS pour un montant